Postrock Partners LLC Buys New Shares in Chemed Co. (NYSE:CHE)

Postrock Partners LLC acquired a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,103 shares of the company's stock, valued at approximately $584,000.

Other large investors have also recently added to or reduced their stakes in the company. CIBC Asset Management Inc lifted its holdings in Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after buying an additional 22 shares during the period. EP Wealth Advisors LLC lifted its holdings in Chemed by 1.9% in the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company's stock valued at $814,000 after buying an additional 25 shares during the period. Independent Advisor Alliance lifted its holdings in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock valued at $1,207,000 after buying an additional 25 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Chemed by 7.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after buying an additional 33 shares during the period. Finally, First Heartland Consultants Inc. raised its holdings in Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company's stock worth $305,000 after purchasing an additional 34 shares during the period. 95.85% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on CHE shares. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada increased their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday.

Remove Ads

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins bought 145 shares of the firm's stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

Chemed Price Performance

CHE traded down $2.45 during mid-day trading on Tuesday, hitting $605.62. The stock had a trading volume of 96,441 shares, compared to its average volume of 87,729. The stock's fifty day simple moving average is $561.91 and its 200-day simple moving average is $564.94. The firm has a market capitalization of $8.86 billion, a price-to-earnings ratio of 30.60, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $653.75.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed's payout ratio is 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.